Erica Palmer

651 total citations
15 papers, 405 citations indexed

About

Erica Palmer is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Erica Palmer has authored 15 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Erica Palmer's work include Histone Deacetylase Inhibitors Research (7 papers), Peptidase Inhibition and Analysis (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Erica Palmer is often cited by papers focused on Histone Deacetylase Inhibitors Research (7 papers), Peptidase Inhibition and Analysis (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Erica Palmer collaborates with scholars based in United States and Czechia. Erica Palmer's co-authors include Alejandro Villagra, Melissa Hadley, Satish Noonepalle, Rohan Fernandes, Debarati Banik, Maria Gracia-Hernandez, Juliana Cano‐Mejia, Katherine B. Chiappinelli, Cyril Bařinka and Jie Chen and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer Research.

In The Last Decade

Erica Palmer

15 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erica Palmer United States 9 251 188 118 65 34 15 405
Hossein Saeedi Iran 10 146 0.6× 117 0.6× 88 0.7× 29 0.4× 55 1.6× 20 320
Jared M. Newton United States 12 166 0.7× 184 1.0× 140 1.2× 97 1.5× 55 1.6× 19 424
Annelie Lindström Sweden 10 107 0.4× 152 0.8× 105 0.9× 18 0.3× 64 1.9× 17 424
Marcin Jasiński Poland 7 144 0.6× 213 1.1× 227 1.9× 49 0.8× 52 1.5× 11 446
Audrey Lequeux Luxembourg 5 123 0.5× 157 0.8× 171 1.4× 94 1.4× 188 5.5× 6 404
Siddesh V. Hartimath Singapore 12 89 0.4× 241 1.3× 179 1.5× 33 0.5× 17 0.5× 30 433
Annunziata Nigro Italy 7 100 0.4× 136 0.7× 172 1.5× 65 1.0× 34 1.0× 11 316
Yaqun Li China 5 106 0.4× 182 1.0× 113 1.0× 28 0.4× 36 1.1× 10 320
Rochelle Fletcher United States 7 166 0.7× 229 1.2× 177 1.5× 53 0.8× 44 1.3× 10 445
Anna Capasso United States 11 178 0.7× 168 0.9× 33 0.3× 28 0.4× 39 1.1× 23 343

Countries citing papers authored by Erica Palmer

Since Specialization
Citations

This map shows the geographic impact of Erica Palmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erica Palmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erica Palmer more than expected).

Fields of papers citing papers by Erica Palmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erica Palmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erica Palmer. The network helps show where Erica Palmer may publish in the future.

Co-authorship network of co-authors of Erica Palmer

This figure shows the co-authorship network connecting the top 25 collaborators of Erica Palmer. A scholar is included among the top collaborators of Erica Palmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erica Palmer. Erica Palmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Gomez, Stephanie, Melissa Hadley, Elisa Arthofer, et al.. (2022). Inhibiting DNA methylation and RNA editing upregulates immunogenic RNA to transform the tumor microenvironment and prolong survival in ovarian cancer. Journal for ImmunoTherapy of Cancer. 10(11). e004974–e004974. 24 indexed citations
2.
Lin, Jianqing, Erica Palmer, Christian Zevallos‐Delgado, et al.. (2021). Phase I Study of Entinostat in Combination with Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer. The Oncologist. 26(12). e2136–e2142. 12 indexed citations
3.
Balakrishnan, Preethi B., Juliana Cano‐Mejia, Jaclyn Andricovich, et al.. (2021). CD137 agonist potentiates the abscopal efficacy of nanoparticle-based photothermal therapy for melanoma. Nano Research. 15(3). 2300–2314. 28 indexed citations
4.
Lin, Jianqing, et al.. (2021). Phase I study of entinostat in combination with enzalutamide for treatment of patients with castration-resistant prostate cancer.. Journal of Clinical Oncology. 39(6_suppl). 96–96. 2 indexed citations
5.
Gomez, Stephanie, Melissa Hadley, James I. McDonald, et al.. (2021). Loss of Adar1 increases T cell migration and prolongs survival in ovarian cancer. The Journal of Immunology. 206(1_Supplement). 57.21–57.21. 1 indexed citations
6.
Sharma, Sambad, Satish Noonepalle, Erica Palmer, et al.. (2021). Abstract 1268: A novel treatment approach for melanoma by dually targeting MCT1 and MCT4 lactate transporters. Cancer Research. 81(13_Supplement). 1268–1268. 1 indexed citations
7.
Banik, Debarati, Satish Noonepalle, Melissa Hadley, et al.. (2020). HDAC6 Plays a Noncanonical Role in the Regulation of Antitumor Immune Responses, Dissemination, and Invasiveness of Breast Cancer. Cancer Research. 80(17). 3649–3662. 50 indexed citations
8.
Moufarrij, Sara, Aneil Srivastava, Stephanie Gomez, et al.. (2020). Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer. Scientific Reports. 10(1). 3470–3470. 73 indexed citations
9.
10.
11.
Knox, Tessa, Eva Sahakian, Debarati Banik, et al.. (2019). Abstract LB-074: Priming the tumor microenvironment with epigenetic modifiers to overcome resistance to immune checkpoint inhibitors. Cancer Research. 79(13_Supplement). LB–74. 1 indexed citations
12.
Banik, Debarati, et al.. (2018). Abstract 48: Targeting HDAC6 to reduce the aggressiveness of metastatic breast cancer in immunotherapy. Cancer Research. 78(13_Supplement). 48–48. 1 indexed citations
13.
Noonepalle, Satish, Jennifer Kim, Melissa Hadley, et al.. (2018). Abstract 5126: Modulation of lactate in the tumor microenvironment with lactate transporter inhibitor in a melanoma syngeneic mouse model. Cancer Research. 78(13_Supplement). 5126–5126. 2 indexed citations
14.
Sturgeon, Kathleen M., Lorraine T. Dean, Erica Palmer, et al.. (2016). Commercially available lifestyle modification program: randomized controlled trial addressing heart and bone health in BRCA1/2+ breast cancer survivors after risk-reducing salpingo-oophorectomy. Journal of Cancer Survivorship. 11(2). 246–255. 19 indexed citations
15.
Kelley, G.G., et al.. (1961). THE ISOLATION AND PROPAGATION OF HUMAN EPIDERMOID CARCINOMA CELLS RESISTANT TO 6-MERCAPTOPURINE1. American Journal of Epidemiology. 73(2). 231–235. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hossein Saeedi Breakdown of academic impact, for papers by Jared M. Newton Breakdown of academic impact, for papers by Annelie Lindström Breakdown of academic impact, for papers by Marcin Jasiński Breakdown of academic impact, for papers by Audrey Lequeux Breakdown of academic impact, for papers by Siddesh V. Hartimath Breakdown of academic impact, for papers by Annunziata Nigro Breakdown of academic impact, for papers by Yaqun Li Breakdown of academic impact, for papers by Rochelle Fletcher Breakdown of academic impact, for papers by Anna Capasso
Rankless by CCL
2026